Literature DB >> 32332401

Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Number 215.

Jorma A Paavonen1, Robert C Brunham.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32332401     DOI： 10.1097/AOG.0000000000003857

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  3 in total

1.  Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).

Authors:  Jane R Schwebke; Ryan Sobel; Janet K Gersten; Steven A Sussman; Samuel N Lederman; Mark A Jacobs; B Todd Chappell; David L Weinstein; Alfred H Moffett; Nkechi E Azie; David A Angulo; Itzel A Harriott; Katyna Borroto-Esoda; Mahmoud A Ghannoum; Paul Nyirjesy; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2022-06-10       Impact factor: 20.999

2.  Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).

Authors:  R Sobel; P Nyirjesy; M A Ghannoum; D A Delchev; N E Azie; D Angulo; I A Harriott; K Borroto-Esoda; J D Sobel
Journal:  BJOG       Date:  2021-11-08       Impact factor: 7.331

3.  Antimicrobial Susceptibility Testing of Metronidazole and Clindamycin against Gardnerella vaginalis in Planktonic and Biofilm Formation.

Authors:  Ting Li; Zhan Zhang; Fengjuan Wang; Yuanhui He; Xiaonan Zong; Huihui Bai; Zhaohui Liu
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-06-16       Impact factor: 2.471
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.